Skip to content
Creative Medical Technology Holdings, Inc. logo

Creative Medical Technology Holdings, Inc.

CELZ

Creative Medical Technology Holdings is a commercial-stage biotechnology company focused on regenerative medicine across immunotherapy, endocrinology, urology, neurology, and orthopedics.

Market cap
$5.15M-27.5%

Table of contents

Earnings

Next report

Aug 14, 2026 (In 2 weeks)
EPS estimate-$0.39

Competitors

Profile

Creative Medical Technology Holdings is a commercial-stage biotechnology company focused on regenerative medicine across immunotherapy, endocrinology, urology, neurology, and orthopedics. The company develops and commercializes proprietary stem cell and immune cell therapies that leverage both autologous and allogenic platforms to treat chronic conditions such as Type 1 Diabetes and degenerative disc disease. Its core value proposition lies in its ability to reprogram immune cells and utilize perinatal tissue-derived cells to induce tissue regeneration with reduced toxicity and high scalability.

Competitive position

The company holds a robust intellectual property portfolio with multiple FDA-cleared Phase I/II clinical trials and Orphan Drug and Fast Track designations for its lead candidates.

GeographiesUnited States
Customer segmentsPatients with chronic diseases, Specialist physicians, Government and military agencies
Business modelR&D intensive, Licensing, Clinical stage development
SuppliersPerinatal tissue donors, GMP-grade cell manufacturing facilities, Molecular sequencing providers, AI and machine learning software
CustomersSpecialized outpatient clinics, Hospitals, Clinical research organizations, Veterans and military personnel
Listed2009
Employees4.0
CEOTimothy Warbington
FilingsSEC EDGAR

Questions, answered.

What is Creative Medical Technology Holdings, Inc.'s market cap?
Creative Medical Technology Holdings, Inc. (CELZ) has a market capitalization of $5.1M and trades on NASDAQ.
Who are Creative Medical Technology Holdings, Inc.'s competitors?
Creative Medical Technology Holdings, Inc.'s key competitors include Longeveron Inc., BioRestorative Therapies, Inc., Pluri Inc. Common Stock, and others. These companies compete in similar markets and product categories.
Who does Creative Medical Technology Holdings, Inc. partner with?
Creative Medical Technology Holdings, Inc.'s notable partners include Greenstone Biosciences Inc., Jadi Cell LLC, Roth Capital Partners, and others.
What subsidiaries does Creative Medical Technology Holdings, Inc. have?
Creative Medical Technology Holdings, Inc.'s subsidiaries include Creative Medical Technologies, Inc., ImmCelz, Inc., StemSpine, Inc., and others.
Where is Creative Medical Technology Holdings, Inc. headquartered?
Creative Medical Technology Holdings, Inc. is headquartered in United States of America and employs approximately 4 people. It has been publicly traded since 2009.